First-line (1L) Nivolumab (NIVO) Plus Chemotherapy (chemo) Vs Chemo in Patients (pts) with Advanced Gastric Cancer, Gastroesophageal Junction Cancer, and Esophageal Adenocarcinoma (GC/GEJC/EAC): 5-Year (y) Follow-Up of Chinese Pts from CheckMate 649.
Journal of Clinical Oncology(2025)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要